News about Vaccine Information Statements
This page offers the latest information about vaccine information statements currently under development.
IMPORTANT: By Federal law, all vaccine providers must give patients, or their parents or legal representatives, the appropriate Vaccine Information Statement (VIS) whenever a vaccination is given.
May 17, 2013
Minor update to Gardasil VIS
The pregnancy registry for Gardasil has been terminated by the manufacturer. Consequently, the reference to the registry has been removed from Section 4 of the Gardasil VIS. This is the only change. Stocks of the previous VIS may still be used as long as patients are made aware that the registry no longer exists. The updated VIS is available from CDC's VIS webpage, and has an edition date of 5/17/13.
May 9, 2013
A new VIS for Tdap, incorporating updated recommendations for pregnant women, is now available. The existing Td/Tdap VIS should continue to be used for patients receiving Td, until an updated Td VIS is available.
April 29, 2013
Several VISs already contain barcodes to help you electronically capture information in the statement. Eventually all VISs will contain a barcode. Learn about barcodes.
Work on an updated Hib VIS is also beginning. It will probably contain information about MenHibrix, regardless of whether a separate MenHibrix VIS is developed.
Influenza VISs for 2013-14 are being reviewed and we are hopeful that official clearance will begin soon. We also hope that this will be the first flu VIS that will remain valid for more than one flu season.
Work is beginning on a new meningococcal VIS, to incorporate recommendations from the recently published ACIP statement. We expect it will take at least several months to accomplish the necessary reviews and clearance. Discussions are ongoing regarding whether a separate VIS for MenHibrix will be produced.
An updated rotavirus VIS is temporarily on hold while some new safety data are being reviewed.
An updated YF VIS should be out of clearance after several minor comments from subject-matter experts are addressed.
March 1, 2013
CDC released an updated Pneumococcal Conjugate (PCV13) VIS with an edition date of 2/27/13. The update primarily added information for adults receiving the vaccine. (3/1/13)
February 27, 2013
Beginning in 2013, each new or updated VIS will be accompanied with a "Provider Information" document, which will
- Summarize relevant ACIP recommendations
- Include more detailed information about indications, schedules, and precautions
- Contain other information that gives providers a quick reference to help address common patients' questions. An example of this is the Provider Information: PCV13 VIS [115KB, 2 pages].
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
Content last reviewed on August 24, 2010
Content Source: National Center for Immunization and Respiratory Diseases